ArticleCardiology journal2022

NOAC versus warfarin in the treatment of atrial fibrillation during the first three months after bioprosthetic aortic valve replacement.

Marta Piepiorka-Broniecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.